Business
Research Reports Initiated on Healthcare Stocks GeneNews, Spectral Medical, ProMIS Neurosciences, and Novadaq Technologies
LONDON, UK / ACCESSWIRE / February 8, 2017 / Active Wall St. announces the list of stocks fo...
About this update from Spectral Medical Inc
[{"type":"text","content":"Research Reports Initiated on Healthcare Stocks GeneNews, Spectral Medical, ProMIS Neurosciences, and Novadaq TechnologiesLONDON, UK / ACCESSWIRE / February 8, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Medical Diagnostics & Research industry. Companies recently under review include GeneNews, Spectral Medical, ProMIS Neurosciences, and Novadaq Technologies. Get all of our free research reports by signing up at:\nhttp://www.activewallst.com/register/\nOn Tuesday, February 07, 2017, at the end of trading session, the Toronto Exchange Composite index ended the day at 15,498.80, 0.27% higher, on a total volume of 395,537,017 shares.\nAdditionally, the Healthcare index was slightly up by 0.38%, ending the session at 71.27.\nActive Wall St. has initiated research reports on the following equities: GeneNews Ltd. (TSX: GEN), Spectral Medical Inc. (TSX: EDT), ProMIS Neurosciences Inc. (TSX: PMN), and Novadaq Technologies Inc. (TSX: NDQ). Register with us now for your free membership and research reports at:\nhttp://www.activewallst.com/register/\nGeneNews Ltd\nOn Tuesday, shares in Markham, Canada headquartered GeneNews Ltd recorded a trading volume of 106,240 shares. The stock ended the day 3.23% higher at $0.32. GeneNews' stock has surged 966.67% in the past one year. Shares of the Company, which focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications, are trading below its 50-day and 200-day moving averages. The stock's 50-day moving average of $0.35 is above its 200-day moving average of $0.34. See our research report on GEN.TO at:\nhttp://www.activewallst.com/registration-3/?symbol=GEN\nSpectral Medical Inc.\nToronto, Canada headquartered Spectral Medical Inc.'s stock finished Tuesday's session flat at $0.26 with a total volume of 355,880 shares traded. Spectral Medical's shares have gained 33.33% in the past three months. Shares of the Company, which focuses on the development and commercialization of theranostic treatment for septic shock in North America, are trading below its 50-day and 200-day ...